You are here

Chronic Lymphocytic Leukaemia in Older Patients (CLL)

Aims
To develop guidelines for diagnosis and treatment of elderly patients with CLL. The key areas for discussion are structured under four headings:
1. Characterization of the group of elderly and geriatric patients
2. Specific aspects of diagnostic assessment in elderly and comorbid patients and the impact of comorbidity on outcome
3. Prognostic markers in elderly/geriatric CLL patients
4. Treatment goals and treatment options

Task Force Members

Chairs: Reinhard Stauder, Austria & Anders Österborg, Sweden

Writing Committee
Barbara Eichhorst, Germany
Valentin Goede, Germany
Marije Hamaker, the Netherlands
Kamil Kaplanov, Russian Federation
Irina Poddubnaya, Russian Federation
Tait Shanafelt, USA
Lukas Smolej, Czech Republic
Jennifer A Woyach, USA
Loic Ysebaert, France

Reviewing Committee
Ulrich Wedding (Germany), SIOG publication committee
Harvey Jay Cohen (USA)
Michael Hallek (Germany)
Emili Montserrat (Spain)
Christian Geisler (Denmark)

Publication

2016
Management of chronic lymphocytic leukaemia in the elderly: position paper of a SIOG Task Force. Stauder R, Eichhorst B, Hamaker M, Kaplanov K, Morrison V, Österborg A, Poddubnaya I, Woyach JA, Shanafelt T, Smolej L, Ysebaert L, Goede V. Ann Oncol. 2016 Nov 1. pii: mdw547. [Epub ahead of print]

This project was supported by unrestricted grants from Janssen Pharmaceutica N.V., Gilead and Astellas.